Total Funding
85
59
Total FundingVenture - Series Unknown raised
Growth Score 85 in past quarter
-6 pts
Heat Score 59 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9979
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.
- Ajay Shah: Co-Founder and CEO
Dino Di Carlo: Co-founder and Board MemberPast Role: Vortex Biosciences, Co-founder and Board Member
About the Company
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases, revolutionizing diagnostics using cell mechanics and machine learning.
The company was founded in 2013 by Ajay Shah and Dino Di Carlo and is based in San Francisco, California.